me ,later in the dream...? a snake was continuously biting my foot it hurt but i did nothing about it just stood there like nothing was happening can someone help me understand this dream!?
me ,later in the dream...? a snake was continuously biting my foot it hurt but i did nothing about it just stood there like nothing was happening can someone help me understand this dream!?
me ,later in the dream...? a snake was continuously biting my foot it hurt but i did nothing about it just stood there like nothing was happening can someone help me understand this dream!?
MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has retained Clinical Development & Support Services, Ltd. (CDSS) of Cheshire, England to manage its planned Phase IIb clinical trial in the United Kingdom for MCT-125, the Company's lead drug candidate for treatment of primary multiple...
Eisai Inc. announced preliminary results from a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection versus either a low-dose chemotherapy agent or supportive care in elderly patients with acute myeloid leukemia (AML), a life-threatening cancer of the blood that generally...
Novartis Pharmaceuticals Corporation ("Novartis") announced that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced...
Orlando, 26 June 2010: Linagliptin, a dipeptidyl dipeptidase (DPP)-4 inhibitor being developed by Boehringer Ingelheim, achieves significant reductions in blood glucose in patients with type 2 diabetes both as monotherapy and in combination with other commonly used hypoglycaemic agents...
Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) presented positive data from a completed Phase 2a clinical study of Azedra™, (Ultratrace™ iobenguane I 131 or Ultratrace I-131-MIBG), the Company's lead oncology therapeutic that targets neuroblastoma, a common childhood cancer. Phase 2a...
I have a cat, though she JUST turned 10 months so technically a kitten who - the past couple days has been acting really strange. She WILL NOT let anyone get near her unless you surprise her enough not to get away. Which is not normal for her. She's by no means a lap cat, she won't stay next to...
I have a cat, though she JUST turned 10 months so technically a kitten who - the past couple days has been acting really strange. She WILL NOT let anyone get near her unless you surprise her enough not to get away. Which is not normal for her. She's by no means a lap cat, she won't stay next to...
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced today that a phase 2a study of NU1618, the company's lead program, met its primary endpoint of reduction in serum uric acid (sUA) levels in patients with hyperuricemia. "This successful...
Relypsa, Inc., announced the initiation of patient enrollment in a Phase 2, open-label titration clinical study of the company's lead drug candidate, RLY5016, in heart failure patients with chronic kidney disease. RLY5016 is a novel non-absorbed oral potassium binder intended to prevent and...
Revotar Biopharmaceuticals AG / Revotar Biopharmaceuticals AG Starts Phase II Clinical Trial in COPD Patients with inhaled Bimosiamose processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. Revotar Biopharmaceuticals AG today announced the...
Data from the first phase III clinical trial of NovoCure's NovoTTF device for treatment of patients with recurrent glioblastoma (GBM) were presented as a late breaking abstract during the Neuro-Oncology session at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Study...
PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a second Phase 1B clinical safety and pilot efficacy study with PMX-60056, a small synthetic...
All my life I've liked boys.
When I was about 13 I started to have crushes on girls, but only little ones, in which I didn't really want to have sex with them, I just wanted to hold them,kiss them and cuddle them. That was it.
Now at 16, I want to sleep with them, and I'm not really falling for...
Repligen Corporation (Nasdaq: RGEN) announced that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving...
VIVUS, Inc. (Nasdaq: VVUS) announced that phase 3 data on avanafil, a next generation oral phosphodiesterase type 5 (PDE5) inhibitor therapy being investigated for the treatment of erectile dysfunction (ED), will be presented next Tuesday at the American Urological Association (AUA) 2010 Annual...
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Dr. Claire Verschraegen of the University of New Mexico, Albuquerque, lead author of the abstract on the palifosfamide study entitled, "A phase II randomized controlled trial of palifosfamide plus doxorubicin vs. doxorubicin in patients...
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has announced further positive data on the first forty subjects in its Phase 2 clinical trial of PV-10 for metastatic melanoma, with an objective response ("OR") observed in 61% of subjects...